Enhancing Adolescent and Young Adult Oncology Research Within the National Clinical Trials Network: Rationale, Progress, and Emerging Strategies.
Document Type
Article
Publication Date
10-1-2015
Institution/Department
Pediatrics, Hematology, Oncology
Journal Title
Seminars in oncology
MeSH Headings
Adolescent, Adult, Biomedical Research, Cooperative Behavior, Humans, Medical Oncology, National Cancer Institute (U.S.), Neoplasms, Pediatrics, Transition to Adult Care, United States, Young Adult
Abstract
Adolescent and Young Adult Oncology (AYAO, including patients 15-39 years of age) is an emerging discipline in the field of cancer treatment and research. Poorer survival outcomes for this population and characteristic age-related challenges in care have called attention to the need for increased AYAO research. This chapter outlines pressing questions and reviews recent progress in AYAO research within the current organizational structure of the federal clinical trials enterprise, emphasizing how the United States National Cancer Institute's National Clinical Trials Network (NCTN) has created novel opportunities for collaborative AYAO research among the pediatric and adult NCTN groups. Potential strategies for expanding AYAO research, both within the NCTN and with other partners in the federal and advocacy domains are identified.
ISSN
1532-8708
First Page
740
Last Page
747
Recommended Citation
Weiss, Aaron R; Nichols, Craig R; and Freyer, David R, "Enhancing Adolescent and Young Adult Oncology Research Within the National Clinical Trials Network: Rationale, Progress, and Emerging Strategies." (2015). Maine Medical Center. 1747.
https://knowledgeconnection.mainehealth.org/mmc/1747
